Jennifer Keen, MD

Pulmonary Medicine
Accepting new patients
Sees patients age 18 and up
Harron Lung Center Washington Square
Schedule onlineCall 215-829-5027
Headshot of Jennifer Keen, MD
Penn Medicine Provider

About me

  • Director, Pulmonary Hypertension & Pulmonary Vascular Disease, Pennsylvania Hospital
  • Assistant Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)

My education and training

  • Medical School: Indiana University Hospital
  • Residency: Indiana University Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Keen is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Keen, J.L., Modi, P., Crespo, M.M., Bermudez, C., Courtwright, A. Survival After Extracorporeal Membrane Oxygenation Bridge to Lung Retransplantation , Annals of Thoracic Surgery Short Reports, 3(1): 2025,150-155

Clancy C, Hartz W, Keen J, Gandler AJ Double Trouble: Isolated right ventricular stress-induced cardiomyopathy in a patient with prior left ventricular stress-induced cardiomyopathy , Chest 2024: 2024

Keen, J.L., Al-Naamani, N., Ventetuolo, C.E. The Future of PAH Treatment , Advances in Pulmonary Hypertension, 22(1): 2023,55-61

Prisco, S. Z., Hartweck, L., Keen, J. L., Vogel, N., Kazmirczak, F., Eklund, M., Hemnes, A. R., Brittain, E. L., & Prins, K. W. Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension. , Frontiers in cardiovascular medicine, 9(940932): 2022,published on-line

Keen J, Kim H. Bronchiolitis Obliterans Associated with FLNA Mutation , American Thoracic Society: 2022

Keen, J., Prisco, S. Z., & Prins, K. W. Sex Differences in Right Ventricular Dysfunction: Insights From the Bench to Bedside. , Frontiers in physiology, 11(published on-line): 2021,623129

Keen J, Prisco S, Prins K. Increased Methylglyoxal Production Impairs Right Ventricle Function in Preclinical Pulmonary Arterial Hypertension , American Thoracic Society: 2021

Keen, J. L., & Thenappan, T. Shifting gears: the search for group 3 pulmonary hypertension treatment. , Current opinion in pulmonary medicine, 27(5): 2021,296-302

Tatah J, Keen J.L, Prisco SZ, Pritzker M, Thenappan T, Prins KW. Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease. , Chest, 161(1): 2021,232-236

Keen J, Patil JM. Tacrolimus-Induced Akinetic Mutism in a Bilateral Lung Transplant Patient. , American Thoracic Society: 2020